Literature DB >> 25625721

Multipoint pacing by a left ventricular quadripolar lead improves the acute hemodynamic response to CRT compared with conventional biventricular pacing at any site.

Francesco Zanon1, Enrico Baracca2, Gianni Pastore2, Lina Marcantoni2, Chiara Fraccaro3, Daniela Lanza3, Claudio Picariello3, Silvio Aggio3, Loris Roncon3, Fabio Dell'Avvocata3, GianLuca Rigatelli3, Domenico Pacetta4, Franco Noventa5, Frits W Prinzen6.   

Abstract

BACKGROUND: Response to cardiac resynchronization therapy (CRT) remains challenging. Pacing from multiple sites of the left ventricle (LV) has shown promising results.
OBJECTIVE: The purpose of this study was to systematically compare the acute hemodynamic effects of multipoint pacing (MPP) by means of a quadripolar lead with conventional biventricular (BiV) pacing.
METHODS: Twenty-nine patients (23 men; mean age 72 ± 12 years; LV ejection fraction 29% ± 7%; 15 with ischemic cardiomyopathy, 17 with left bundle branch block; mean QRS 183 ± 23 ms) underwent CRT implantation. Per patient, 3.2 ± 1.2 different veins and 6.3 ± 2.4 pacing sites were tested. LV electrical delay (Q-LV) was measured at each location, along with the increase in LV dP/dtmax (maximum rate of rise of LV pressure) obtained by BiV and MPP. The effect of MPP, by means of simultaneous pacing from distal and proximal dipoles, was investigated at all available sites.
RESULTS: Overall, 3.2 ± 1.2 different MPP measurements were collected per patient. When all sites were considered, LV dP/dtmax increased from 951 ± 193 mm Hg/s at baseline to 1144 ± 255 and 1178 ± 259 mm Hg/s on BiV and MPP, respectively. When the best site was considered, LV dP/dtmax increased from a baseline value of 942 ± 202 mm Hg/s to 1200 ± 267 mm Hg/s (BiV) and 1231 ± 267 mm Hg/s (MPP). The mean QRS duration at any site during MPP and conventional CRT was 171 ± 18 and 175 ± 16 ms (P = .003), respectively.
CONCLUSION: Compared with BiV pacing at any LV site, MPP yielded a small but consistent increase in hemodynamic response. A correlation between the increase in hemodynamics and Q-LV on MPP was observed for all measurements, including those taken at the best and worst sites. The MPP-induced improvement in contractility was associated with significantly greater narrowing of the QRS complex than conventional BiV pacing.
Copyright © 2015 Heart Rhythm Society. Published by Elsevier Inc. All rights reserved.

Entities:  

Keywords:  Cardiac resynchronization therapy; Hemodynamics; Multipoint pacing

Mesh:

Year:  2015        PMID: 25625721     DOI: 10.1016/j.hrthm.2015.01.034

Source DB:  PubMed          Journal:  Heart Rhythm        ISSN: 1547-5271            Impact factor:   6.343


  27 in total

Review 1.  Updates in Cardiac Resynchronization Therapy for Chronic Heart Failure: Review of Multisite Pacing.

Authors:  Antonios P Antoniadis; Ben Sieniewicz; Justin Gould; Bradley Porter; Jessica Webb; Simon Claridge; Jonathan M Behar; Christopher Aldo Rinaldi
Journal:  Curr Heart Fail Rep       Date:  2017-10

Review 2.  Multisite pacing via a quadripolar lead for cardiac resynchronization therapy.

Authors:  Alexandre Bodin; Arnaud Bisson; Clémentine Andre; Bertrand Pierre; Laurent Fauchier; Dominique Babuty; Nicolas Clementy
Journal:  J Interv Card Electrophysiol       Date:  2019-07-18       Impact factor: 1.900

Review 3.  [Current impact of cardiac implantable electronic devices].

Authors:  J Kuschyk; B Rudic; M Borggrefe; I Akin
Journal:  Herz       Date:  2017-04       Impact factor: 1.443

Review 4.  [Multipoint pacing-more CRT or a waste of battery power?]

Authors:  J Müller-Leisse; C Zormpas; T König; D Duncker; C Veltmann
Journal:  Herz       Date:  2018-11       Impact factor: 1.443

Review 5.  Multisite Pacing for Cardiac Resynchronization Therapy: Promise and Pitfalls.

Authors:  Antonios P Antoniadis; Jonathan M Behar; Simon Claridge; Tom Jackson; Manav Sohal; Christopher Aldo Rinaldi
Journal:  Curr Cardiol Rep       Date:  2016-07       Impact factor: 2.931

6.  Rationale and design of a randomized trial to assess the safety and efficacy of MultiPoint Pacing (MPP) in cardiac resynchronization therapy: The MPP Trial.

Authors:  Gery Tomassoni; James Baker; Raffaele Corbisiero; Charles Love; David Martin; Robert Sheppard; Seth J Worley; Kwangdeok Lee; Imran Niazi
Journal:  Ann Noninvasive Electrocardiol       Date:  2017-05-18       Impact factor: 1.468

7.  Clinical outcome of left ventricular multipoint pacing versus conventional biventricular pacing in cardiac resynchronization therapy: a systematic review and meta-analysis.

Authors:  Feng Hu; Lihui Zheng; Ligang Ding; Zhongpeng Du; Erpeng Liang; Lingmin Wu; Gang Chen; Xiaohan Fan; Yan Yao; Yu Jiang
Journal:  Heart Fail Rev       Date:  2018-11       Impact factor: 4.214

8.  Association of QRS narrowing with response to cardiac resynchronization therapy-a systematic review and meta-analysis of observational studies.

Authors:  George Bazoukis; Katerina K Naka; Alawi Alsheikh-Ali; Gary Tse; Konstantinos P Letsas; Panagiotis Korantzopoulos; Tong Liu; Cynthia Yeung; Michael Efremidis; Konstantinos Tsioufis; Adrian Baranchuk; Stavros Stavrakis
Journal:  Heart Fail Rev       Date:  2020-09       Impact factor: 4.214

Review 9.  Cardiac resynchronization therapy in heart failure patients: tough road but clear future.

Authors:  Ziyu Wang; Yongquan Wu; Junmeng Zhang
Journal:  Heart Fail Rev       Date:  2020-10-24       Impact factor: 4.214

10.  Impact of synchronous atrioventricular delay optimization on left ventricle flow force angle evaluated by echocardiographic particle image velocimetry.

Authors:  Valter Bianchi; Alfonso R Martiniello; Jan Mangual; Vincenzo Tavoletta; Gianni Pedrizzetti; Giovanni Tonti; Valentina Maria Caso; Pio Caso; Antonio D'Onofrio
Journal:  J Interv Card Electrophysiol       Date:  2021-01-20       Impact factor: 1.900

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.